Clik here to view.
Occlutech recalls cardiac implant on dislodgement risk
Structural heart disease implant developer Occlutech said it’s recalling some of its Occlutech left atrial appendix occluders over risks of dislocation of the device both during and post-procedure. The...
View ArticleClik here to view.
Feds enact final rule barring earnings stripping from inversions
The U.S. Federal Government yesterday issued final rules barring the tax-reduction technique known as earnings stripping from corporate tax inversions. Earnings stripping happens when a U.S. subsidiary...
View ArticleClik here to view.
Private equity players vie for BSN Medical
BC Partners, Blackstone and CVC are reportedly among the private equity players lining up to bid next week for BSN Medical. Citing “several people close to the matter,” Reuters reported that BSN...
View ArticleClik here to view.
Philips wins FDA nod for Lumify S4-1 transducer
Royal Philips (NYSE:PHG) said today it won FDA 510(k) clearance for an S4-1 cardiac transducer for its Lumify smart-diagnostic ultrasound device. The newly cleared S4-1 transducer is pocket-sized and...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 14, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Cash works, but activity trackers may do little to boost exercise
(Reuters) – Health might be its own reward, but even cash incentives only work in the short term to motivate people to exercise more and activity trackers add little benefit, according to a study from...
View ArticleClik here to view.
Five ways to avoid scope creep in clinical trial execution
By Dana Fletcher, August 18, 2016 You’ve heard the story before. FDA has approved the protocol. The sponsor has contracted with a Clinical Research Organization (CRO) to initiate and manage their...
View ArticleClik here to view.
Lucerno Dynamics raises $6.3 in Series A
Biomarker sensor developer Lucerno Dynamics raised $6.3 million in a Series A round of equity financing, according to an SEC filing posted today. Money in the round includes $5.2 million in new funds...
View ArticleClik here to view.
Researchers look to create massive human cell ‘atlas’
Scientists launched a global initiative on Friday to map out and describe every cell in the human body in a vast atlas that could transform researchers’ understanding of human development and disease....
View ArticleClik here to view.
FDA approves Genentech’s Lucentis pre-filled ranibizumab syringe
Genentech, a member of the Roche group (PINK:RHHBY), said today that it won FDA clearance for its Lucentis (ranibizumab injection) pre-filled syringes. The anti-VEGF medicine is FDA-approved to treat...
View ArticleClik here to view.
Aerogen touts study of Solo vibrating mesh for aerosol drug delivery
Aerogen today touted results from a study showing a 32% reduction in hospital admissions when patients were treated using its Solo vibrating mesh aerosol drug delivery system, compared to a...
View ArticleClik here to view.
Physics-modeling software solves drug-delivery engineering problem
Software that models the laws of physics is usually used by theoretical physicists. But a multi-physics program based on “1st principles” can be used in real-world applications, as evidenced by a...
View ArticleClik here to view.
St. Jude Medical forms cybersecurity advisory panel
St. Jude Medical (NYSE:STJ) said today that it’s forming a Cybersecurity Medical Advisory Board as it looks to “advance cybersecurity standards in the medical device industry by working with experts...
View ArticleClik here to view.
Sleep apnea may increase diabetes risk
(Reuters) — Obstructive sleep apnea is linked with an increased risk of developing Type II diabetes, new research shows. The findings support recommendations from the International Diabetes Federation...
View ArticleClik here to view.
U.S. diabetics have worsening blood sugar
(Reuters) — The number of U.S. diabetics with healthy blood sugar levels has declined in recent years, a study suggests. Researchers analyzed data on 1.6 million adults with diabetes from 2006 to 2013....
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 17, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Outsourcing Bioskills Workshops To Contract Research Organizations
Medical device companies frequently need to conduct bioskills training events either to educate their sales force on new devices/technology, to educate new hires to the sales force, or to provide...
View ArticleClik here to view.
Mast Therapeutics inks deal with Philips Respironics for iNeb aerosol...
Mast Therapeutics (NYSE:MSTX) said today that its subsidiary Aires Pharmaceuticals landed a collaborative agreement with Royal Philips (NYSE:PHG) sleep and respiratory care subsidiary Philips...
View ArticleClik here to view.
Doctors still order imaging for low back pain, against recommendations
(Reuters) — Many doctors who order CT or MRI scans for patients with low back pain do so fearing that patients will be upset if they do not get imaging and because there is too little time to explain...
View ArticleClik here to view.
Report: Medtech seeing shrinking VC funds, less startups
AdvaMed today released a report cautioning about a “future at risk” in medtech, warning that a lack of startups and shrinking venture capital funds could compromise the industry as a whole. The medtech...
View Article
